Follow
Michele Signore
Title
Cited by
Cited by
Year
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
E Vacchelli, Y Ma, EE Baracco, A Sistigu, DP Enot, F Pietrocola, H Yang, ...
Science 350 (6263), 972-978, 2015
4622015
Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme
R Pallini, L Ricci-Vitiani, GL Banna, M Signore, D Lombardi, M Todaro, ...
Clinical Cancer Research 14 (24), 8205-8212, 2008
4302008
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy
M Bartucci, S Svensson, P Romania, R Dattilo, M Patrizii, M Signore, ...
Cell Death & Differentiation 19 (5), 768-778, 2012
2142012
Targeting apoptosis pathways in cancer stem cells
M Signore, L Ricci-Vitiani, R De Maria
Cancer letters 332 (2), 374-382, 2013
1572013
Exosomes from human colorectal cancer induce a tumor-like behavior in colonic mesenchymal stromal cells
L Lugini, M Valtieri, C Federici, S Cecchetti, S Meschini, M Condello, ...
Oncotarget 7 (31), 50086, 2016
1542016
Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases
L Grassi, R Alfonsi, F Francescangeli, M Signore, ML De Angelis, ...
Cell death & disease 10 (3), 201, 2019
1482019
Integrin α7 is a functional marker and potential therapeutic target in glioblastoma
TL Haas, MR Sciuto, L Brunetto, C Valvo, M Signore, ME Fiori, ...
Cell stem cell 21 (1), 35-50. e9, 2017
1252017
Mesenchymal differentiation of glioblastoma stem cells
L Ricci-Vitiani, R Pallini, LM Larocca, DG Lombardi, M Signore, ...
Cell Death & Differentiation 15 (9), 1491-1498, 2008
1182008
Heat shock proteins and their role in heart injury
G Delogu, M Signore, A Mechelli, G Famularo
Current opinion in critical care 8 (5), 411-416, 2002
1152002
Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor
A Zeuner, M Signore, D Martinetti, M Bartucci, C Peschle, R De Maria
Cancer research 67 (10), 4767-4773, 2007
1112007
Metabolic/proteomic signature defines two glioblastoma subtypes with different clinical outcome
G Marziali, M Signore, M Buccarelli, S Grande, A Palma, M Biffoni, A Rosi, ...
Scientific reports 6 (1), 21557, 2016
1052016
Inhibition of DNA Methylation Sensitizes Glioblastoma for Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Mediated Destruction
A Eramo, R Pallini, F Lotti, G Sette, M Patti, M Bartucci, L Ricci-Vitiani, ...
Cancer research 65 (24), 11469-11477, 2005
1032005
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells
G Manic, M Signore, A Sistigu, G Russo, F Corradi, S Siteni, M Musella, ...
Gut 67 (5), 903-917, 2018
942018
Reverse-phase protein microarrays: application to biomarker discovery and translational medicine
A VanMeter, M Signore, M Pierobon, V Espina, LA Liotta, EF Petricoin Iii
Expert review of molecular diagnostics 7 (5), 625-633, 2007
922007
Drug repurposing for the treatment of glioblastoma multiforme
C Abbruzzese, S Matteoni, M Signore, L Cardone, K Nath, JD Glickson, ...
Journal of Experimental & Clinical Cancer Research 36, 1-11, 2017
862017
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
F Francescangeli, P Contavalli, ML De Angelis, S Careccia, M Signore, ...
Journal of Experimental & Clinical Cancer Research 39, 1-17, 2020
802020
Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth
M Buccarelli, QG D’Alessandris, P Matarrese, C Mollinari, M Signore, ...
Journal of Experimental & Clinical Cancer Research 40, 1-17, 2021
792021
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
M Musella, A Guarracino, N Manduca, C Galassi, E Ruggiero, A Potenza, ...
Nature immunology 23 (9), 1379-1392, 2022
782022
Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells
M Bartucci, S Svensson, L Ricci-Vitiani, R Dattilo, M Biffoni, M Signore, ...
Endocrine-related cancer 17 (3), 823-833, 2010
772010
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells
LR Mangiapane, A Nicotra, A Turdo, M Gaggianesi, P Bianca, S Di Franco, ...
Gut 71 (1), 119-128, 2022
762022
The system can't perform the operation now. Try again later.
Articles 1–20